Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 42,272,703
- Total 13F value
- $544,351,939
- Share change
- -854,361
- SEC-reported price per share
- $12.84
- Number of holders
- 99
- Value change
- -$11,748,534
- Number of buys
- 50
- Number of sells
- 38
- Shares outstanding
- 64,445,857
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
99
Top holders
10
STOK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Ownership snapshot
Top reported holders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Skorpios Trust
Disclosed value leader
Skorpios Trust
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F
Highest disclosed value: $190,801,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Skorpios Trust has the largest disclosed position value at $190.8M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Skorpios Trust's linked filing trail.
Disclosed position value
Top 5
Skorpios Trust
$190.8M
RTW INVESTMENTS, LP
$48.24M
FMR LLC
$39.17M
MORGAN STANLEY
$34.56M
VANGUARD GROUP INC
$26.35M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Skorpios Trust |
13F
Company
|
—
denominator unverified
|
$190,801,000
14,443,681 shares
|
— | 30 Jun 2022 |
| RTW INVESTMENTS, LP |
13F
Company
|
—
denominator unverified
|
$48,241,000
3,651,823 shares
|
— | 30 Jun 2022 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$39,168,000
2,964,987 shares
|
— | 30 Jun 2022 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$34,556,000
2,615,874 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$26,354,000
1,995,033 shares
|
— | 30 Jun 2022 |
| Redmile Group, LLC |
13F
Company
|
—
denominator unverified
|
$26,331,000
1,993,268 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
99
Shares
42,272,703
Rows available
99
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
88
Q3 2022 holders
99
Holder diff
11
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend